Feature

Special Article

The State of Clinical Pathways: Results From the Inaugural Journal of Clinical Pathways Benchmarking Survey

11/15/2019

Clinical pathways have become an integral part of oncology care. In use in oncology practices as early as the early 2000s, the prevalence of clinical pathways is expected to increase as the focus on value-based care...

...

11/15/2019

Journal of Clinical Pathways

Research Reports

Use of Biomarker Testing in Lung Cancer Among Puerto Rico and Florida Physicians: Results of a Comparative Study

10/18/2019

Steven K. Sutton , PhD;

Alberto Chiappori , MD;

Iffat Alam ;

Vani N. Simmons , PhD;

Matthew B. Schabath , PhD;

Teresita Muñoz-Antonia , PhD;

Gwendolyn P. Quinn , PhD;

Abstract: Biomarker-driven therapies are the gold standard of treatment in lung cancer. Recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than non-Hispanic...

...

10/18/2019

Journal of Clinical Pathways

Research Reports

Development of a Low Resource Tool for Optimizing Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System

10/18/2019

Robert Parke , MD;

David Hernandez , MD;

Anita L. Sabichi , MD;

Vlad C. Sandulache , MD, PhD;

Peter Gerngross , DDS;

Ricky Morlen , DMD;

George Chen , MD;

Caroline Hudson , MD;

David C. Wilde , MD;

Andrew T. Huang , MD;

Banner Logan , DDS, MD;

Scott Charnitsky , PA;

Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...

Abstract: The Veterans...

10/18/2019

Journal of Clinical Pathways

From the Field

Role of a Nurse Navigator and Care Pathways in an Integrated Prostate Cancer Care Program

09/20/2019

Frank dela Rama , RN, MS, AOCNS, AGN-BC;

Abstract: An Integrated Prostate Cancer Program was developed and implemented at the Palo Alto Medical Foundation for Health Care, Research and Education in 2006. The Prostate Program offers surgery, radiation...

...

09/20/2019

Journal of Clinical Pathways

Perspectives

Primary Care-Oriented Pathways to Support Population-Based Payment Models

09/20/2019

Catherine S. Hwang , MSPH;

Anders Chen , MD, MHS;

Joshua M. Liao , MD, MSc, FACP;

Leah M. Marcotte , MD, FACP;

Abstract: While clinical pathways have been identified as a key strategy for succeeding under inpatient episode-based payment models, they have not been widely touted as part of primary care population-based...

...

09/20/2019

Journal of Clinical Pathways

Research Reports

Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients

07/08/2019

Nakhle Saba , MD;

Hana Safah , MD;

Chenguang Zhang , MS;

Yordanka N. Koleva , PhD;

Jerrold Yeo , PsyD;

Lisa C. Solursh-Abbrecht , PsyD;

Abstract: Hematopoietic stem cell transplant (HSCT) for blood and bone marrow disorders is a costly procedure that requires complex treatment regimens. In addition to disease-related factors, comorbidity and...

...

07/08/2019

Journal of Clinical Pathways

Research Reports

Drug Costs vs Probability of Survival in Lung Cancer: Impact of Dosage, Duration, and Immune Checkpoint Inhibitor Combinations

06/18/2019

Helmy M. Guirgis , MD, PhD;

Abstract: Clinical guidelines and pathways recommend use of immune checkpoint inhibitors (ICI) in first- and second-line treatment of advanced/metastatic non-small cell lung cancer (amNSCLC). There is an unmet need...

...

06/18/2019

Journal of Clinical Pathways

Perspectives

On the Horizon for Value-Based Oncology Care: Predictive Analytics, Novel Therapy Pricing Pressures, New Payment Models, and a Rise in Complex Data Sources

06/18/2019

Jennifer Webster , MS;

Charles Saunders , MD;

Abstract: January 2019 represented another major inflection point for the Oncology Care Model (OCM), marking the halfway point of the 5-year program. Overall, while OCM participants have expressed concerns about...

...

06/18/2019

Journal of Clinical Pathways

From the Field

The Supportive Care of Oncology Patients (SCOOP) Pathway: A Novel Approach to Improving the Patient Experience in the Curative Treatment of Cancer

05/15/2019

Nicholas Petrelli , MD, FACS;

Edith J. Johnson , PhD, MBA;

Christopher Koprowski , MD, MBA;

Karen Sites , MSN, RN, OCN, CCM;

Abstract: It was hypothesized that by introducing more intense supportive care and enhanced nurse navigation in high-acuity curable cancer patients, we could achieve the same results noted in patients with advanced...

...

05/15/2019

Journal of Clinical Pathways

Perspectives

Value-Based Management of Clinical Pathways: An Applied Framework

05/15/2019

Kimberley Herner , MD;

Christopher P. Chen , MD, MBA;

Joshua M. Liao , MD, MSc, FACP;

Leah M. Marcotte , MD, FACP;

Abstract: For health care organizations, clinical pathways have historically been important tools for translating medical evidence into practice and delivering high-quality, cost-conscious (ie, high-value) care....

...

05/15/2019

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products